Key points are not available for this paper at this time.
This JAMA Forum discusses artificial intelligence tools and the regulatory challenges for global regulatory bodies, including the US Food and Drug Administration, in creating new policies to ensure the safety and efficacy of these tools for patients.
Gottlieb et al. (Thu,) studied this question.